While each adrenergic receptor sub-type (α and β) leads to different physiologic functions, the effects of adrenergic signaling in EOC have been shown to be largely mediated by β-adrenergic receptors in tumor cells, specially stimulation β2-AR [6,14,18,21,22,25]. Here, ADRB2 is linked to neoplasm.